Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Barclays Maintains Overweight on Elastic, Raises Price Target to $200

Barclays analyst Raimo Lenschow maintains Elastic (NYSE:ESTC) with a Overweight and raises the price target from $185 to $200.

byvishwanath@benzinga.com

September 17, 2021

1 minute read

Barclays analyst Raimo Lenschow maintains Elastic (NYSE:ESTC) with a Overweight and raises the price target from $185 to $200.

Phunware Steams Up Hybrid Work Initiatives After Facebook, Salesforce

By Anusuya Lahiri

August 23, 9:24 AM

Enterprise cloud platform Phunware Inc (NASDAQ:PHUN) collaborated with HID Global to integrate and offer its Smart Workplace Solution to customers using HID’s access control…

CRM

Analyst Ratings

Expert Ratings for HCA Healthcare

By Benzinga Insights

July 6, 1:06 PM

Within the last quarter, HCA Healthcare (NYSE:HCA) has observed the following analyst ratings:

HCA

HC Wainwright & Co. Maintains Buy on Akerna, Lowers Price Target to $2.5

By Benzinga Newsdesk

February 25, 7:15 AM

HC Wainwright & Co. analyst Scott Buck maintains Akerna (NASDAQ:KERN) with a Buy and lowers the price target from $5 to $2.5.

KERN

Edward Jones Initiates Coverage On GE HealthCare Techs with Hold Rating

By Benzinga Newsdesk

January 4, 1:57 PM

Edward Jones analyst John Boylan initiates coverage on GE HealthCare Techs (NASDAQ:GEHC) with a Hold rating.

GEHC

Barclays Maintains Overweight on Elastic, Raises Price Target to $200

Related Posts

Phunware Steams Up Hybrid Work Initiatives After Facebook, Salesforce

Expert Ratings for HCA Healthcare

HC Wainwright & Co. Maintains Buy on Akerna, Lowers Price Target to $2.5

Edward Jones Initiates Coverage On GE HealthCare Techs with Hold Rating